AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03933059 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Psychotherapy
Description: Cognitive Processing Therapy is a primarily cognitive form of Cognitive Behavioral Therapy, which has been shown to be effective at reducing symptoms of PTSD.
Study NCT03447834 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Selective intracoronary hypothermia + PPCI
Description: Selective intracoronary hypothermia is a new technique, recently tested for safety and feasibility in the SINTAMI trial. The procedure starts by advancing a guidewire beyond the occlusion in the culprit artery, followed by an OTWB that is inflated at the location of the occlusion, at a low pressure (4 atm), to prevent reperfusion. After that, a pressure/temperature wire will be advanced along the inflated OTWB and is placed in the distal coronary artery. Then the guidewire is removed and the lumen is used for infusion of saline. During the 'occlusion phase', saline at room temperature is infused for 10 minutes with distal coronary temperature 6-8°C below body temperature. After that, the balloon of the OTWB is deflated. Simultaneously, infusion is started with saline of 4°C, the so called 'reperfusion phase'. This is continued for 10 more minutes. After that, the OTWB can be retracted and the procedure can continue not different from routine PPCI.
Study NCT03447834 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard PPCI
Description: PPCI per routine
Study NCT04301973 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Stool collection
Description: There is no intervention with a product in this study. The healthy subject has just to come 2 times in the clinical trial unit for clinical exam including urinary pregnancy test, fill life habits and diet questionnaires, and provide one stool sample for the 2nd visit, after 2 weeks of alimentary restrictions.
Study NCT00926523 — intervention group
Intervention type: OTHER
Intervention: Blood Gas
Description: Subject will have both venous and arterial blood draws to assess for the bloods content of MIF
Study NCT00926523 — intervention group
Intervention type: OTHER
Intervention: Pulmonary Exercise Test
Description: Subject will ride exercise bike to assess their pulmonary function level.
Study NCT00926523 — intervention group
Intervention type: OTHER
Intervention: Spirometry
Description: To assess subjects lung function
Study NCT00926523 — intervention group
Intervention type: OTHER
Intervention: Breath Condensate Collector
Description: Subject with use breathing apparatus to allow researchers to collect breath condensate to assess level of MIF in breathe condensate.
Study NCT05009355 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: antioxidant
Study NCT04215367 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High phenolic EVOO intake
Description: During the pilot dietary intervention patients with CLL consumed before their meals, 40 ml/day high phenolic EVOO for 6 months
Study NCT04215367 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: No High phenolic EVOO intake
Description: Medical record of each patient's was followed during 6 month before dietary the intervention
Study NCT03147326 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: FDG-PET-CT
Description: scanning method
Study NCT03147326 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: NaF-PET-CT
Description: scanning method
Study NCT03147326 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Whole-body MRI
Description: scanning method
Study NCT02902926 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low FODMAPs Diet
Description: Instruct to design and eat Low Fermentable，Oligo-，Di-，Mono-saccharides And Polyols(FODMAPs) Diet
Study NCT02902926 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Diet instruction
Description: Answer the doubt and help the patient get the diet knowlege about the IBS.
Study NCT02902926 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet instruction
Description: Answer the doubt and help the patient get the diet knowlege about the IBS.
Study NCT02016846 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Liraglutide
Study NCT02016846 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04772976 — intervention group
Intervention type: OTHER
Intervention: Observational study, not applicable
Description: Observational study, not applicable
Study NCT04393727 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CONVALESCENT PLASMA
Description: Convalescent plasma will be collected by healthy donors, cured by COVID-19 and, after standard preparation and dosage of neutralizing antibodies, will be administered to patients with SARS-CoV2 pneumonia
Study NCT01521741 — intervention group
Intervention type: OTHER
Intervention: Breast Cancer-Related Lymphedema Screening
Description: All patients enrolled in the trial will receive prospective BCRL screening from their pre-operative baseline throughout their breast cancer treatment process. All participants will be measured with perometry, bioimpedance spectroscopy, and patient-reported outcome measures.
Study NCT01712178 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Adalimumab, current formulation
Description: Current formulation adalimumab 40 mg every other week
Study NCT01712178 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adalimumab, new formulation
Description: New formulation adalimumab 40 mg every other week
Study NCT06394258 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Description: Stereotactic body radiotherapy to the vaginal cuff with the aim to reproduce adjuvant high dose rate (HDR) brachytherapy dose distribution by means of external beam radiotherapy in patients operated for intermediate risk endometrial carcinoma
Study NCT02142842 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous adipose tissue stromal vascular fraction and platelet rich plasma
Study NCT02598674 — intervention group
Intervention type: DRUG
Intervention: Iodohippurate
Description: An injection of non-radioactive iodohippurate (0.07 mL/kg) will be administered to determine renal plasma flow (RPF)
Study NCT02598674 — intervention group
Intervention type: PROCEDURE
Intervention: 24 hour ambulatory Blood Pressure
Description: Ambulatory blood pressure (BP) monitoring will be performed using a commercially available device (TIBA Ambulo 2400) for 24 hours with measurements every 30 minutes while awake and every hour during sleep.
Study NCT02598674 — intervention group
Intervention type: PROCEDURE
Intervention: Peripheral Arterial Tonometry
Description: The peripheral arterial tonometry (PAT) device measures changes in the cutaneous circulation that correlate with flow-mediated dilatation.
Study NCT02598674 — intervention group
Intervention type: PROCEDURE
Intervention: Pulse Wave Velocity
Description: Carotid-femoral and carotid-radial pulse wave velocities (PWV), validated markers of individual cardiovascular risk, will be determined by applanation tonometry using SphygmoCorVx technology (AtCor Medical). PWV is an index of the overall stiffness of a vascular segment between measurement sites 59. Thus, while carotid-femoral PWV is an index of the overall stiffness of proximal (central) arteries, the overall stiffness of peripheral arteries contributes relatively more to carotid-radial PWV.
Study NCT02598674 — intervention group
Intervention type: DRUG
Intervention: Gadolinium
Description: Dotarem Gadolinium (GD)- Gadoterate Meglumine (0.07 to 0.14 mL/kg) will be used to determine GFR.
Study NCT00880841 — intervention group
Intervention type: DRUG
Intervention: Buprenorphine / Naloxone
Description: oral formulation of buprenorphine / naloxone
Study NCT02439164 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: specific benzodiazepine agonist midazolam will be used titrate to desired sedation level, its specific antagonist flumazenil will also be used
Study NCT02439164 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: specific benzodiazepine agonist midazolam will be used titrate to desired sedation level, its specific antagonist flumazenil will also be used
Study NCT03277040 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CSA membership
Description: Bi-weekly fresh food delivery
Study NCT01979432 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Cardiovascular evaluation
Study NCT03920956 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ABPM service by Pharmacists
Description: Patients will receive ABPM services provided by a pharmacist and complete a patient satisfaction survey
Study NCT00651209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir
Description: All patients receive 600 mg/day, oral telbivudine for 24 weeks. Patients with non-detectable HBV DNA continue 600 mg/day, oral telbivudine for the remaining treatment period (Sub-group 1) Patients with detectable HBV DNA receive 300 mg/day, oral tenofovir plus 600 mg/day, oral telbivudine for the remaining treatment period (Sub-group 2)
Study NCT02576470 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Biofeedback
Description: Motor learning is improvement in movement overtime, followed by retaining what was learned. To determine whether movements are improving, kinematics must be assessed over time, beginning with defining specific kinematic goals, then continually re-evaluating goals throughout rehabilitation while providing the participants with biofeedback. Biofeedback is fundamental in motor learning, because it increases guidance and motivation, supplements losses in intrinsic feedback (proprioception), and facilitates generalization and retention. Biofeedback enhances the training of novel movements and could be essential for training swallowing maneuvers. Biofeedback training will occur 3 times.
Study NCT02576470 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Biofeedback
Description: Motor learning is improvement in movement overtime, followed by retaining what was learned. To determine whether movements are improving, kinematics must be assessed over time, beginning with defining specific kinematic goals, then continually re-evaluating goals throughout rehabilitation while providing the participants with biofeedback. Biofeedback is fundamental in motor learning, because it increases guidance and motivation, supplements losses in intrinsic feedback (proprioception), and facilitates generalization and retention. Biofeedback enhances the training of novel movements and could be essential for training swallowing maneuvers. Biofeedback training will occur 3 times.
Study NCT02576470 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Biofeedback
Description: Motor learning is improvement in movement overtime, followed by retaining what was learned. To determine whether movements are improving, kinematics must be assessed over time, beginning with defining specific kinematic goals, then continually re-evaluating goals throughout rehabilitation while providing the participants with biofeedback. Biofeedback is fundamental in motor learning, because it increases guidance and motivation, supplements losses in intrinsic feedback (proprioception), and facilitates generalization and retention. Biofeedback enhances the training of novel movements and could be essential for training swallowing maneuvers. Biofeedback training will occur 3 times.
Study NCT02576470 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: Weak direct currents can be applied non-invasively, transcranially and painlessly. Such application leads to transient changes in corticomotor excitability that are fully reversible. There are no known risks of tDCS of the brain, other than mild local discomfort at the electrode sites.The tDCS sessions will be separated by at least 24hrs, the electrode pads will not be used more than 4 times and they will be clean with a sterile saline solution.
Study NCT02576470 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Direct Current Stimulation
Description: Weak direct currents can be applied non-invasively, transcranially and painlessly. Such application leads to transient changes in corticomotor excitability that are fully reversible. There are no known risks of tDCS of the brain, other than mild local discomfort at the electrode sites.The tDCS sessions will be separated by at least 24hrs, the electrode pads will not be used more than 4 times and they will be clean with a sterile saline solution.
Study NCT02576470 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial Reward
Description: Motor learning training can be enhanced by adjuvant techniques such as non-invasive neural stimulation and explicit reward. Both influence the primary motor cortex (M1), a key neural substrate of motor skill learning. Non-invasive neural stimulation reduces dysphagia after stroke as measured with subjective swallowing severity scales, however it is unknown whether it could also enhance swallowing maneuver training. Explicit reward (i.e. financial) incentivizes successful gains during motor training. Explicit reward has never been investigated in swallowing rehabilitation. However, it has been shown that increasing stress and financial penalty can reduce swallowing frequency in healthy adults.
Study NCT02095288 — intervention group
Intervention type: PROCEDURE
Intervention: Blood draw
Description: This is a single blood donation, no drugs or devices administered
Study NCT02576470 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: targeted dysphagia training maneuver
Description: training swallowing maneuvers or compensatory techniques (referred to as targeted dysphagia training throughout this document) that might reduce their swallowing pathophysiology
Study NCT02576470 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: targeted dysphagia training maneuver
Description: training swallowing maneuvers or compensatory techniques (referred to as targeted dysphagia training throughout this document) that might reduce their swallowing pathophysiology
Study NCT02576470 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: targeted dysphagia training maneuver
Description: training swallowing maneuvers or compensatory techniques (referred to as targeted dysphagia training throughout this document) that might reduce their swallowing pathophysiology
Study NCT05927662 — intervention group
Intervention type: PROCEDURE
Intervention: lumbar discectomy
Description: mini-open discectomy
Study NCT01473004 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sir-Spheres®
Description: Sir-Spheres® Yttrium-90 microspheres given intra-hepatic; once for each lobe involved separated by 4 weeks.
Study NCT00657020 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine
Description: Nicotine lozenge containing 4 mg of nicotine
Study NCT02576470 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Videofluoroscopy (VF) and Barium
Description: The videofluoroscopy (VF) and barium will be used to record swallowing in all participant groups. This will capture full resolution VF images of all subjects in real time in the lateral view. From the digital recording, image sequencing will be exported to an image processing computer system and archived. The image intensifier will be focused on the lips, posterior pharyngeal wall, hard palate, and just below the upper esophageal sphincter (UES), providing a full view of the oral cavity and neck. A simultaneously recorded time-code will facilitate frame-by-frame data analysis. VF is the only option for visualizing swallowing kinematics during the pharyngeal swallow.
Study NCT02576470 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Videofluoroscopy (VF) and Barium
Description: The videofluoroscopy (VF) and barium will be used to record swallowing in all participant groups. This will capture full resolution VF images of all subjects in real time in the lateral view. From the digital recording, image sequencing will be exported to an image processing computer system and archived. The image intensifier will be focused on the lips, posterior pharyngeal wall, hard palate, and just below the upper esophageal sphincter (UES), providing a full view of the oral cavity and neck. A simultaneously recorded time-code will facilitate frame-by-frame data analysis. VF is the only option for visualizing swallowing kinematics during the pharyngeal swallow.
Study NCT02576470 — intervention group
Intervention type: RADIATION
Group type: SHAM_COMPARATOR
Intervention: Videofluoroscopy (VF) and Barium
Description: The videofluoroscopy (VF) and barium will be used to record swallowing in all participant groups. This will capture full resolution VF images of all subjects in real time in the lateral view. From the digital recording, image sequencing will be exported to an image processing computer system and archived. The image intensifier will be focused on the lips, posterior pharyngeal wall, hard palate, and just below the upper esophageal sphincter (UES), providing a full view of the oral cavity and neck. A simultaneously recorded time-code will facilitate frame-by-frame data analysis. VF is the only option for visualizing swallowing kinematics during the pharyngeal swallow.
Study NCT02576470 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial Magnetic Stimulation (TMS) will be used to provide a single-pulse to the brain.
Study NCT02576470 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial Magnetic Stimulation (TMS) will be used to provide a single-pulse to the brain.
Study NCT02576470 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Submental Electromyography
Description: Submental Electromyography (sEMG) is used to train participants swallowing maneuvers.
Study NCT02576470 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Submental Electromyography
Description: Submental Electromyography (sEMG) is used to train participants swallowing maneuvers.
Study NCT02576470 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Submental Electromyography
Description: Submental Electromyography (sEMG) is used to train participants swallowing maneuvers.
Study NCT02026349 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: favipiravir
Description: Administered twice daily over 5 consecutive days for a total of 10 doses.~* Day 1: 1800 mg twice daily (loading doses)~* Days 2 through 5: 800 mg twice daily
Study NCT02026349 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered twice daily over 5 consecutive days for a total of 10 doses.
Study NCT03594006 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: CCI; cancer care coordination instrument
Description: Designed to assess cancer patients' perceptions of care coordination
Study NCT02415946 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sinus floor augmentation (lateral)
Study NCT02415946 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sinus floor augmentation (transcrestal)
Study NCT00827567 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RAD 001
Description: RAD 001-10 mg by mouth once everyday
Study NCT00748241 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Astra Tech Fixture ST
Description: Astra Tech Fixture ST Ø 3.5 and 4.5 cm in lengths of 9, 11, 13, 15, 17 and 19 mm.
Study NCT01102634 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Description: Application of TENS over acupuncture points
Study NCT01102634 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Description: Placebo
Study NCT02054780 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive Behavioral Therapy
Description: We propose using TF-CBT to address stress related problems (SRP) and reduce HIV risk behaviors. OVC lack behavioral and cognitive skills and intention necessary to use the available information and resources to prevent HIV. For example, internalizing problems are related to HIV risk through low self-efficacy, poor assertiveness skills, and reduced ability to negotiate safe sex. Given evidence on the link between abuse/trauma and elevated HIV risk, researchers have called for overlap between evidence-based mental health treatments like TF-CBT and HIV prevention programs. Some studies have found that skills-oriented interventions reduced HIV-risk behaviors among minority and troubled youths. An intervention study using CBT increased condom use and decreased high-risk sexual behaviors among runaway youths in a short-term follow-up evaluation. However, these studies were done in Western countries; their relevance to OVC in Africa is unproven.
Study NCT02054780 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychosocial Counseling
Description: The curriculum Psychosocial Care and Counseling was developed for HIV Infected Children and Adolescents. The goal is to enable health care providers to provide safe supportive counseling and support services to HIV infected youth and their families. The course materials are designed to be adapted to different cultures and needs. The 14 modules cover child development, family systems, communicating with children, disclosure and adherence and legal/ethical issues. The course teaches basic counseling skills with children such as listening and play. It explores and challenges barriers to care such as caregivers' fear and reluctance to disclose an HIV positive diagnosis to a child, discussing adolescent sexuality, and practical issues such as inadequate legislation governing child rights. The curriculum was adapted for Zambia and endorsed by the MoH.
Study NCT02152007 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1% sirolimus cream (TD201 1%)
Description: 1% sirolimus cream (TD201 1%)